These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9436017)

  • 1. The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population.
    French AL; McCullough ME; Rice KT; Schultz ME; Gordin FM
    Gerontology; 1998; 44(1):56-60. PubMed ID: 9436017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity response in tetanus toxoid sensitized rhesus monkeys: predictor of anergy and value in tuberculin skin testing.
    Davis JA; Hayre M; Linn JM
    Lab Anim Sci; 1988 Aug; 38(4):413-6. PubMed ID: 3184848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tetanus toxoid for testing cell-mediated immunity.
    Whittingham S; Feery B; Mackay IR
    Aust N Z J Med; 1982 Oct; 12(5):511-4. PubMed ID: 6758748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hypersensitivity skin testing in the Thai adult population.
    Thongngarm T; Valyasevi AM; Pattanapanyasat K; Udompunturak S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S195-200. PubMed ID: 17718262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity.
    Delafuente JC; Eisenberg JD; Hoelzer DR; Slavin RG
    JAMA; 1983 Jun; 249(23):3209-11. PubMed ID: 6343648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
    Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
    J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.
    Siripassorn K; Charoenwongse P; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2006; 24(2-3):143-52. PubMed ID: 17136880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of skin test antigens to evaluate PPD anergy.
    Wright PW; Crutcher JE; Holiday DB
    J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cutaneous delayed-type hypersensitivity reaction and T cell proliferative response in elderly nursing home patients: an approach to identifying immunodeficient patients.
    Castle SC; Norman DC; Perls TT; Chang MP; Yoshikawa TT; Makinodan T
    Gerontology; 1990; 36(4):217-29. PubMed ID: 2272525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients.
    Schiffman K; Rinn K; Disis ML
    Breast Cancer Res Treat; 2002 Jul; 74(1):17-23. PubMed ID: 12150448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity to tetanus toxoid in man: in vivo and in vitro studies.
    Johnson C; Walls RS; Ruwoldt A
    Pathology; 1983 Oct; 15(4):369-72. PubMed ID: 6674868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to tetanus toxoid.
    Jacobs RL; Lowe RS; Lanier BQ
    JAMA; 1982 Jan; 247(1):40-2. PubMed ID: 7053439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure.
    Bleavins MR; de la Iglesia FA
    Toxicology; 1995 Jan; 95(1-3):103-12. PubMed ID: 7825177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity.
    Gordon EH; Krouse HA; Kinney JL; Stiehm ER; Klaustermeyer WB
    J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):487-94. PubMed ID: 6355249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed cutaneous hypersensitivity response in patients receiving nutritional support.
    Griffin RE; Champagne CD; Bistrian BR; DiPalma SA; Blackburn GL; Benotti PN
    Clin Pharm; 1983; 2(5):432-5. PubMed ID: 6627869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus.
    Rogers AS; Ellenberg JH; Douglas SD; Henry-Reid L; Peralta L; Wilson CM;
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):273-8. PubMed ID: 11238207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
    Blatt SP; Hendrix CW; Butzin CA; Freeman TM; Ward WW; Hensley RE; Melcher GP; Donovan DJ; Boswell RN
    Ann Intern Med; 1993 Aug; 119(3):177-84. PubMed ID: 8100691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.